Fennec Pharmaceuticals Inc (FENC) returns
Fennec Pharmaceuticals returns over 10 years
$1,000 invested in Fennec Pharmaceuticals ten years ago was worth $5,095 at the close on October 30, 2026, with dividends reinvested: an average return of 17.7% a year. The same $1,000 in the S&P 500 (SPY) became $4,166.
Total return by period
| Period | Total return | A year, on average | $1,000 became | S&P 500 (SPY) |
|---|---|---|---|---|
| 1 month | -3.8% | — | $961.50 | -0.9% |
| 3 months | +3.3% | — | $1,033 | +2.1% |
| Year to date | +33.0% | — | $1,330 | +11.7% |
| 1 year | +22.9% | — | $1,229 | +12.4% |
| 3 years | +48.8% | +14.2% | $1,488 | +88.5% |
| 5 years | +10.6% | +2.0% | $1,106 | +76.0% |
| 10 years | +409.5% | +17.7% | $5,095 | +316.6% |
Fennec Pharmaceuticals return by calendar year
| Year | FENC | S&P 500 (SPY) | Difference |
|---|---|---|---|
| 2026 to date | +33.0% | +11.7% | +21.3% |
| 2025 | +21.8% | +17.7% | +4.1% |
| 2024 | -43.7% | +24.9% | -68.6% |
| 2023 | +16.9% | +26.2% | -9.3% |
| 2022 | +118.2% | -18.2% | +136.4% |
| 2021 | -40.9% | +28.7% | -69.7% |
| 2020 | +14.8% | +18.4% | -3.6% |
| 2019 | +1.7% | +31.2% | -29.5% |
| 2018 | -36.3% | -4.6% | -31.8% |
| 2017 | +368.6% | +21.7% | +346.9% |
| 2016 | +22.6% | +12.0% | +10.6% |
Past returns do not predict future returns. Returns are computed from our daily closes, adjusted for splits and with dividends reinvested on their ex-dates; taxes and trading costs are left out.
See also: FENC financials
No forecast, no recommendation. This page describes Fennec Pharmaceuticals Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.